(1-030) Switching Patients With Obesity From Semaglutide to Tirzepatide Due to Adverse Effects

Sunday, December 7, 2025

3:30 PM - 5:00 PM

Location: Bayside A, Level 1

Federal Agency: Department of Veterans Affairs

Co-Author(s): Jacqueline Cabbiness

Primary Author(s)

Morgan Carroll, PharmD

PGY2 Ambulatory Care Resident
Captain James A. Lovell Federal Health Care Center